Mesothelioma is a devastating diagnosis to receive, but proactive steps can help patients live better quality lives while undergoing treatment. Studies have shown that mesothelioma patients with an improved quality of life also have an improved prognosis—the disease outlook. Doctors know their patients can improve mesothelioma quality of life by focusing on these critical aspects…
Blog
Keytruda and Immunotherapy Drugs for Mesothelioma and Lung Cancer
Using Keytruda to treat lung cancer was recently approved in the European Union after a study demonstrated that this immunotherapy drug reduced the risk of death by 36%. Cancer is a devastating disease, and in Europe, lung cancer is one of the most deadly forms of the disease. “Lung cancer is the leading cause of…
Concerns Over Continued Asbestos Use in America Firing Up at Government Level
Elected officials have shed light on a dangerous issue that’s still not resolved: continued asbestos use in America with contaminated talc powder products. Despite decades of legislation, medical research and public outcry, companies continue to use asbestos-contaminated talc in manufacturing their personal care, hygiene and cosmetic products. Johnson & Johnson® Ignites National Concern Johnson &…
Supreme Court Rules in Favor of Navy Veterans in Asbestos Case
The Supreme Court ordered March 19, 2019 that Navy contractors must warn consumers if replacement parts for their products may contain asbestos, USA Today reports. The case that sparked the ruling was filed by two Navy veterans and their families. The veterans allegedly developed cancer and died after they were exposed to asbestos products during…
Options for Patients Who Stop Responding to Mesothelioma Chemotherapy
Mesothelioma chemotherapy can help ease symptoms and prolong life, but many patients stop responding to treatment after some time. These patients may benefit from participating in clinical trials as promising second-line treatment options are currently under research. Standard chemotherapy for mesothelioma can slow the growth of cancer cells and prevent them from spreading. The most…
Jury Sides Against Johnson & Johnson® in $29.4 Million Talc Lawsuit
Suit Alleged Johnson & Johnson’s Powder Products Caused Cancer A jury in California awarded a woman with cancer and her husband $29.4 million in the latest lawsuit against Johnson & Johnson, according to a report from the Recorder. Teresa Leavitt’s suit claimed Johnson & Johnson’s baby powder led her to develop mesothelioma, a rare form…
Johnson & Johnson® Talc Supplier Files for Bankruptcy Amid Cancer Lawsuits
Johnson & Johnson® talc supplier, Imerys Talc America Inc., supplies the talcum that the pharmaceutical giant uses in their products, including baby powder. The talc supplier has recently filed for bankruptcy in the wake of thousands of lawsuits claiming that Johnson & Johnson talc products cause ovarian cancer and mesothelioma. Imerys Facing Thousands of Lawsuits…
Preclinical Trial for New Mesothelioma Drug Receives EU Funding
The European Union (EU) has awarded Aromics — a Spanish biotechnology company — €1 million (Euros) for its BERMES project that’s working on a novel mesothelioma drug. These funds will allow the company to finish its preclinical trials for this new drug, NAX035. The medical community needs to find effective targeted mesothelioma therapies because the…
U.S. Food and Drug Administration Finds Asbestos in Claire’s and Justice Makeup Products
The Food and Drug Administration revealed March 5 that select makeup products sold by Claire’s and Justice contained asbestos, according to a USA Today report. This announcement comes on the heels of reports dating back to 2017 that previously found asbestos in some of the companies’ products, which are branded to pre-teen girls. According to…
